Launch Accelerator for Biosciences
Program Overview
Introduction to the Launch Accelerator for Biosciences
The Launch Accelerator for Biosciences (IU LAB) is a pioneering academic-industry initiative designed to establish Indiana as a national leader in bioscience discovery. Supported by a $138 million Lilly Endowment Inc. grant, IU LAB aims to leverage Indiana's extensive resources in bioscience discovery, leading to significant advancements in human health.
Program Overview
IU LAB is expected to open in the 16 Tech Innovation District in 2027. The program represents an enormous opportunity to distinguish Indiana and the greater Indianapolis region as an international leader for biosciences research and innovation.
Research and Development
Indiana University has a strong track record of research and development, with:
- $943.4M in total research and development expenditures in FY23
- $359M in NIH Award Dollars in FY24
- 630 direct NIH awards in FY24
Community and University Partners
IU LAB collaborates with various community and university partners, including:
- Indiana Biosciences Research Institute
- Regenstrief Institute
- IU Health
- 16 Tech
- Central Indiana Corporate Partnership (CICP)
- Convergent Bioscience & Technology Institute (CBATI)
- Institute for Human Health & Wellbeing (IH2W)
- Integrated Nanosystems Development Institute (INDI)
- IU School of Medicine
- IU Bloomington
- Luddy School of Informatics, Computing, and Engineering
- Other Institutes, Schools, and Programs
Mission and Objectives
The mission of IU LAB is to drive bioscience innovation, commercialization, and talent development in Indiana. By harnessing the state's extensive resources in bioscience discovery, IU LAB aims to make significant advancements in human health and establish Indiana as a national leader in bioscience discovery.
